PatientsLikeMe ™
Already a member? Log in
Share your real-world treatment experience
with patients just like you.
with patients just like you.
- Select a community
- ALS including PLS and PMA
-
Find out more about the PatientsLikeMe
ALS Community
AVP-923 (DM/Q) Treatment Report
See More Treatments
See all treatments in the PatientsLikeMe system shared by patients just like you.
What is AVP-923 (DM/Q)?
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy and to Determine the Pharmacokinetics of Two Doses of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Pseudobulbar Affect (PBA) in Patients With Amyotrophic Lateral Sclerosis and Multiple Sclerosis
Read more...
Reasons Taken
3 patients in the community are taking or have taken AVP-923 (DM/Q).
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Emotional lability | 2 | 66% |
| Other | 1 | 33% |
Duration
How long current patients have been taking AVP-923 (DM/Q) or how long patients were taking AVP-923 (DM/Q) before stopping.
Currently taking AVP-923 (DM/Q)
Stopped taking AVP-923 (DM/Q)
| 0-1 month | 1-3 months | 3-6 months | 6 months-1year | 1-2 years | 2 years or more |
|---|---|---|---|---|---|
|
0
|
0
|
0
|
0
|
0
|
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 1 | 100% |  |